Associate Director, Program Leader for Reid Family Innovative Therapeutics Unit (ITU)
Seattle, Washington – Swedish Cancer Institute (SCI) and the Institute for Systems Biology (ISB), both in Seattle, Washington, are jointly recruiting an accomplished physician investigator to lead their combined early phase clinical trials program. The role includes medical directorship of the Robert and Jean Reid Family Innovative Therapeutics and Research Unit based at SCI, and an academic appointment at ISB. This is a full-time position, requiring board certification in hematology and/or medical oncology. The program leader will be responsible for the integration of novel clinical trials, specifically early-phase clinical trials, focusing on targeted therapies, to include immune system directed therapies, within the framework of SCI’s personalized medicine platform. The ideal candidate will have expertise in the design and conduct of early phase therapeutic trials as well as in translational research and molecular oncology, being recognized as a national/international leader, or emerging leader in modern cancer therapeutic development, to include immuno-oncology, along with a record of successful grant and/or contract support for clinical research. This position, while translational, is anticipated to be clinically based, with pre-clinical collaborations through the ISB. A wet lab effort at the ISB that supports the translational program can be part of the candidate's role. A disease site focus is encouraged. Additionally, the successful candidate will have a strong record of superb patient care, excellent interpersonal and communication skills, and high emotional intelligence.
Competitive compensation, comprehensive benefits, and an outstanding quality of life are just a few of the defining features of this opportunity. The ISB is a premier biology and biomedical research institute, located in the South Lake Union district of Seattle. The ISB was founded in 1999 by Leroy Hood, and has pioneered the development and application of high throughput biology and computational tools for addressing challenging problems in cancer and other diseases. The ISB and SCI are partnered through a joint relationship with Providence St. Joseph's Health.
FACILITY DESCRIPTION T
he Swedish Cancer Institute is the premier cancer care and clinical research center in the region. The Institute, founded in 1932, now includes more than 150 Swedish affiliated oncologists and oncology surgeons throughout the region. With clinical trials and an environment open to new drug treatments, technology and clinical applications, the institute is a hub of innovation.
Seattle is the Pacific Northwests largest urban center (metro population 3.25 million), with world-class arts and entertainment, a robust economy and an outstanding school system. The city hugs magnificent Puget Sound and offers Olympic and Cascade mountain views to the north, east and south. Seattleites are famously fond of the outdoors, fresh seafood and good coffee.
Swedish Health Services, a not-for-profit health system based in Seattle, operates five renowned hospitals and more than 100 medical clinics offering primary and specialty care. Swedish is a partner organization of the Providence St. Joseph Health (PSJH) family. With hundreds of physician and advanced practice clinician opportunities in virtually all specialties at any given time, PSJH and Swedish offer diverse locations, lifestyles and practice models. Swedish is proud to be an Equal Employment Opportunity organization.